216 related articles for article (PubMed ID: 37113192)
1. The treatment principles and targets for intestinal Behcet's disease.
He K; Wu D
Therap Adv Gastroenterol; 2023; 16():17562848231167283. PubMed ID: 37113192
[TBL] [Abstract][Full Text] [Related]
2. Advances in Management of Intestinal Behçet's Disease: A Perspective From Gastroenterologists.
Cheon JH
J Rheum Dis; 2021 Jan; 28(1):4-16. PubMed ID: 37476392
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.
He K; Yan X; Wu D
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175882
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
Kim DH; Cheon JH
Yonsei Med J; 2016 Jan; 57(1):22-32. PubMed ID: 26632379
[TBL] [Abstract][Full Text] [Related]
5. [Intestinal manifestations of Behçet's disease].
Goloeva RG; Alekberova ZS; Lisitsyna TA; Stepanova EA; Orlova LP
Ter Arkh; 2019 May; 91(5):111-119. PubMed ID: 32598685
[TBL] [Abstract][Full Text] [Related]
6. Confusing untypical intestinal Behcet's disease: Skip ulcers with severe lower gastrointestinal hemorrhage.
Wang ZK; Shi H; Wang SD; Liu J; Zhu WM; Yang MF; Liu C; Lu H; Wang FY
World J Gastrointest Endosc; 2014 Jan; 6(1):27-31. PubMed ID: 24527178
[TBL] [Abstract][Full Text] [Related]
7. Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease.
Lee HJ; Cheon JH
Intest Res; 2017 Jul; 15(3):311-317. PubMed ID: 28670227
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-α agents for refractory intestinal Behçet's disease: case series and meta-analysis.
Zhan S; Liu C; Li N; Li T; Tian Z; Zhao M; Wu D; Chen M; Zeng Z; Zhuang X
Therap Adv Gastroenterol; 2022; 15():17562848221116666. PubMed ID: 36082178
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease.
Hisamatsu T; Hayashida M
Intest Res; 2017 Jul; 15(3):318-327. PubMed ID: 28670228
[TBL] [Abstract][Full Text] [Related]
10. Behçet's disease with intestinal involvement: case-based review.
Dzhus MB; Karasevska TA; Tsaralunga VM; Yurchenko AV; Ivashkivsky OI
Rheumatol Int; 2022 Sep; 42(9):1653-1660. PubMed ID: 35661907
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of intestinal Behçet's disease.
Hisamatsu T; Naganuma M; Matsuoka K; Kanai T
Clin J Gastroenterol; 2014 Jun; 7(3):205-12. PubMed ID: 24883128
[TBL] [Abstract][Full Text] [Related]
12. Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.
Nguyen A; Upadhyay S; Javaid MA; Qureshi AM; Haseeb S; Javed N; Cormier C; Farooq A; Sheikh AB
Inflamm Intest Dis; 2021 Dec; 6(4):175-185. PubMed ID: 35083283
[TBL] [Abstract][Full Text] [Related]
13. Incomplete intestinal obstruction as the possible main complaint in Behcet's disease after surgery for recurrent abdominal aortic pseudoaneurysms: a case report and literature review.
Jiang F; Xiang H; Peng ZY
BMC Cardiovasc Disord; 2018 Dec; 18(1):238. PubMed ID: 30558546
[TBL] [Abstract][Full Text] [Related]
14. Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
Park Y; Cheon JH
Curr Gastroenterol Rep; 2020 Mar; 22(5):24. PubMed ID: 32193746
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab in the treatment of pediatric Behçet's disease: case-based review.
Poddighe D; Mukusheva Z; Dauyey K; Assylbekova M
Rheumatol Int; 2019 Jun; 39(6):1107-1112. PubMed ID: 30976833
[TBL] [Abstract][Full Text] [Related]
16. An unusual presentation of Behçet's disease: intestinal perforation.
Pirildar T; Keser G; Tunç E; Alkanat M; Tunçyürek M; Doğanavşargil E
Clin Rheumatol; 2001; 20(1):61-2. PubMed ID: 11254244
[TBL] [Abstract][Full Text] [Related]
17. [Capsule endoscopy for Behcet's disease-treatment: five cases reports].
Huang Q; Wang XM; Liu YL; Feng GJ; You P
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):366-9. PubMed ID: 27080298
[TBL] [Abstract][Full Text] [Related]
18. Outcome predictors for intestinal Behçet's disease.
Park JJ; Kim WH; Cheon JH
Yonsei Med J; 2013 Sep; 54(5):1084-90. PubMed ID: 23918555
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy.
Han SJ; Kang EA; Park J; Park SJ; Park JJ; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2023 Feb; 64(2):111-116. PubMed ID: 36719018
[TBL] [Abstract][Full Text] [Related]
20. Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings.
Moon CM; Cheon JH; Shin JK; Jeon SM; Bok HJ; Lee JH; Park JJ; Hong SP; Kim TI; Kim NK; Kim WH
Dig Dis Sci; 2010 Oct; 55(10):2904-11. PubMed ID: 20094787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
